Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Maia Fertility secures undisclosed funding to enhance its biotechnology solutions. The round was co-led by Mercantile Life Science Ventures IV and Big Idea Ventures.
PRIVATEJul 31, 2026•9 days ago
Round Type
Venture - Series Unknown
Center DistrictBiotechnologyHealth Care
Investors
Big Idea VenturesMercantile Life Science Ventures Iv
Description
Maia Fertility, a biotechnology startup specializing in mammalian reproductive health, secured an undisclosed strategic funding round. The investment will help expand efficacy studies across commercial cattle operations and optimize delivery systems for livestock. The company aims to establish foundational data for future human medical applications. Led by CEO Nir Arbel, Maia Fertility develops innovative solutions to improve reproductive efficiency in mammals.
Company Information
Company
Maia Fertility
Location
Center District, Israel
About
Maia Fertility is a biotechnology startup specializing in mammalian reproductive health and biological delivery systems. The company develops 'Ferizyme™,' a proprietary enzyme platform aimed at optimizing reproductive efficiency and pregnancy success rates in mammals. They focus on large-scale efficacy studies in commercial cattle operations to prepare for future human medical applications. Led by Founder and CEO Nir Arbel, Maia Fertility aims to integrate agtech solutions into global livestock supply chains.
Predictive Intelligence
Strategic
ML-powered predictions for Maia Fertility's next move
Center DistrictBiotechnologyHealth Care